Krystal Biotech, Inc.KRYSNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+45.3%
5Y CAGR+13.1%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+45.3%/yr
vs +11.8%/yr prior
5Y CAGR
+13.1%/yr
Recent acceleration
Acceleration
+33.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $496.30M | +43.9% |
| 2024 | $344.87M | -3.8% |
| 2023 | $358.33M | +121.3% |
| 2022 | $161.90M | -52.6% |
| 2021 | $341.25M | +27.2% |
| 2020 | $268.27M | +43.1% |
| 2019 | $187.51M | +80.9% |
| 2018 | $103.67M | +109.1% |
| 2017 | $49.59M | +2478.8% |
| 2016 | $1.92M | - |